APPG calls for long term conditions to be part of new pharmacy contract

APPG calls for long term conditions to be part of new pharmacy contract

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

RPS seeks views on draft guidance around polypharmacy

RPS seeks views on draft guidance around polypharmacy

July 13 2018 The Royal Pharmaceutical Society is seeking comments to hone draft guidance on...

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20...

PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

July 10 2018 Pharmacy technicians have indicated concerns about the possibility that their role...

  • APPG calls for long term conditions to be part of new pharmacy contract

    APPG calls for long term conditions to be part of new pharmacy contract

    Monday, 16 July 2018 15:44
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:51
  • RPS seeks views on draft guidance around polypharmacy

    RPS seeks views on draft guidance around polypharmacy

    Friday, 13 July 2018 12:47
  • NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    Wednesday, 11 July 2018 13:02
  • PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

    PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

    Tuesday, 10 July 2018 09:23

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a alert imageJanuary 11 2018

Healthcare professionals are being asked to be extra vigilant when dispensing or prescribing medicines with commonly confused drug names.

The MHRA’s latest Drug Safety Update gives a list of common errors of names that sound alike or look alike:

clobazam (benzodiazepine)

clonazepam (antiepileptic drug)

atenolol (beta blocker)

amlodipine (calcium channel blocker)

propranolol (beta blocker)

prednisolone (corticosteroid)

risperidone (antipsychotic)

ropinirole (dopamine agonist)

sulfadiazine (antibiotic)

sulfasalazine (disease-modifying anti-rheumatic drug)

amlodipine (indicated for hypertension and angina)         

nimodipine (indicated for the prevention of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage)

“We are aware of recent cases, including cases with fatal outcomes, in which patients have received the wrong medicine due to confusion between similarly named or sounding brand or generic names,” said the MHRA. “Since our last Drug Safety Update on drug-name confusion in 2013, we have received Yellow Card reports of harm following confusion between the drugs listed in the table.”

The MHRA says “if pharmacists have any doubt about which medicine is intended, contact the prescriber before dispensing the drug.” They should also “follow local and professional guidance in relation to checking the right medicine has been dispensed to a patient.”

Health professionals are asked to “report suspected adverse drug reactions where harm has occurred as a result of a medication error on a Yellow Card or via local risk management systems that feed into the National Reporting and Learning System.”

Links:
MHRA Drug Safety Update: monthly PDF newsletters        
MHRA Drug Safety Update: monthly PDF newsletter. January 6 2018. 11;6.                 
Drug name confusion DSU – January 2018              
Drug name confusion DSU – April 2013  

Practice News

July 18 2018 Community pharmacists should be among those health professionals who are alerted to a patient being included on the Palliative Care Register, Welsh Assembly Members have recommended.
July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20 hypertensive patients without the need to refer a patient back to the GP. Analysis of 131,419 patient...